Exosomal miR-663b from "M1" macrophages promotes pulmonary artery vascular smooth muscle cell dysfunction through

Honghong Ma1,2, Yang Yu3, Lirong Mo1,2

  • 1Department of Respiratory Medicine, People’s Hospital of Ningxia Hui Autonomous Region, Yinchuan 750000, Ningxia, China.

Aging
|May 4, 2023
PubMed
Abstract

Insights

Exosomal miR-663b from M1 macrophages drives pulmonary hypertension by impairing the AMPK/Sirt1 pathway in pulmonary artery smooth muscle cells. Inhibiting this microRNA alleviates disease progression.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Pathophysiology

Background:

  • Macrophages, particularly M1-polarized macrophages, release inflammatory mediators implicated in pulmonary vascular remodeling.
  • Pulmonary hypertension (PH) involves complex cellular and molecular mechanisms, including macrophage-derived factors.

Purpose of the Study:

  • To investigate the role of exosomal miR-663b from M1 macrophages in pulmonary artery smooth muscle cell (PASMC) dysfunction.
  • To elucidate the mechanism by which exosomal miR-663b contributes to the development of pulmonary hypertension.

Main Methods:

  • Established in vitro and in vivo models of pulmonary hypertension using hypoxia-treated PASMCs and rats.
  • Isolated exosomes from M1-polarized macrophages and applied them to PASMCs.
  • Assessed PASMC proliferation, inflammation, oxidative stress, and migration.
  • Quantified miR-663b and AMPK/Sirt1 pathway components via RT-PCR and Western blot.
  • Confirmed the direct interaction between miR-663b and AMPK using dual luciferase and RNA pull-down assays.

Main Results:

  • miR-663b was upregulated in hypoxia-induced PASMCs and M1 macrophages.
  • Overexpression of miR-663b exacerbated hypoxia-induced PASMC dysfunction, while its inhibition reversed these effects.
  • miR-663b directly targeted and inhibited the AMPK/Sirt1 pathway.
  • AMPK activation mitigated the detrimental effects of miR-663b and M1 macrophage exosomes on PASMCs.
  • In vivo, M1 macrophage-derived exosomes with reduced miR-663b expression ameliorated pulmonary vascular remodeling in PH rats.

Conclusions:

  • Exosomal miR-663b secreted by M1 macrophages promotes PASMC dysfunction and pulmonary hypertension.
  • This process occurs via the suppression of the AMPK/Sirt1 signaling pathway.
  • Targeting exosomal miR-663b presents a potential therapeutic strategy for pulmonary hypertension.